European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite ...

The Federal Circuit reversed finding sufficient written description. The Federal Circuit explained that the written description requirement pertains only to the claims themselves and the construction ...

European pharma companies warned the EU Commission President that potential U.S. tariffs could accelerate the industry’s move to the United States. The EFPIA calls for regulatory reforms to foster ...

Part of the partners' plan is to use Plex's AI to identify potential new uses for existing treatments that can be used to ...

IgAN research, focusing on real-world patient experiences, reveals unmet needs in disease education, affordability, and care navigationEXTON, PA, April 08, 2025 (GLOBE NEWSWIRE) -- Spherix Global ...

The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.

The proportion of foreign nationals in corporate management in Swiss companies “has never been higher", a new report has ...

Leading pharmacy benefit managers are shifting away from lucractive rebates on biologic drugs and toward lower-cost ...

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...